国色A片V一区二区三区下,把女人弄爽特黄a大片,扒开粉嫩小泬直接进视频,久久久久 亚洲 无码 AV 专区

您好,歡迎光臨上海雅吉生物商城!
工作時(shí)間:9:00-18:00
全國(guó)服務(wù)熱線:021-34661276

Brilliant Violet 510™ anti-human CD4 Antibod

訂購(gòu)數(shù)量:
規(guī)格
價(jià)格庫存
訂購(gòu)熱線:021-34661276
我要詢價(jià)
  • 商品詳情
  • 售后服務(wù)
  • 相關(guān)文獻(xiàn)

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Human peripheral T cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510? under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Brilliant Violet 510? excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

The OKT4 antibody binds to the D3 domain of CD4 and does not block HIV binding. Additional reported applications (for the relevant formats) include: immunohistochemistry of frozen sections and blocking of T cell activation. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 317453 and 317454).

In a small subset of individuals, the OKT4 clone does not bind to CD4 due to polymorphisms in CD4.9

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Reinherz EL, et al. 1979. Proc. Natl. Acad. Sci. 76:4061.
  3. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  4. Cicin-Sain L, et al. 2010. J. Immunol. 184:6739. PubMed
  5. Rosenzweig M, et al. 2001. J. Med. Primatol. 30:36.
  6. Linder J, et al. 1987. Am. J. Pathol. 127:1.
  7. Boche D, et al. 1999. J. Neurovirol. 5:232. (IHC)
  8. Reinherz EL, et al. 1979. Proc. Natl. Acad. Sci. USA. 76:4061. (Immunogen)
  9. Lederman S, et al. 1991. Mol Immunol. 28:1171-81.
Product Citations
  1. Carre C, et al. 2021. iScience. 24:102970. PubMed
  2. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  3. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  4. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  5. Wang S, et al. 2021. Exp Ther Med. 21:37. PubMed
  6. Peng S et al. 2019. Cell Rep. 28(10):2728-2738 . PubMed
  7. Kasper M, et al. 2021. Elife. 10:. PubMed
  8. Vijayakumar B, et al. 2022. Immunity. . PubMed
  9. Vetsika EK, et al. 2021. Cancers (Basel). 13:. PubMed
  10. Caduff N, et al. 2021. Cell Reports. 35(5):109056. PubMed
  11. Guedan S, et al. 2018. JCI Insight. 3. PubMed
  12. Priyanto H, et al. 2021. J Clin Tuberc Other Mycobact Dis. 22:100214. PubMed
  13. Herrera FG, et al. 2019. Int J Radiat Oncol Biol Phys. 103:320. PubMed
  14. Heger L, et al. 2018. Front Immunol. 9:744. PubMed
  15. Tu HA, et al. 2020. Cell Rep Med. 1:100155. PubMed
  16. Breen EC, et al. 2022. iScience. 25:104488. PubMed
  17. Kalina T, et al. 2020. Front Immunol. 11:371. PubMed
  18. Idorn M, et al. 2018. Oncoimmunology. 7:e1412029. PubMed
  19. Khaitan A, et al. 2016. PLoS One. 11: 0161786. PubMed
  20. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  21. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  22. Meckiff BJ, et al. 2020. Cell. 183(5):1340-1353.e16. PubMed
  23. Wing A, et al. 2018. Cancer Immunol Res. 6:605. PubMed
  24. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  25. Riese P, et al. 2022. Nat Commun. 13:6894. PubMed
  26. Menges D, et al. 2022. Nat Commun. 13:4855. PubMed
  27. Willmann K, et al. 2014. Nat Commun. 5:5360. PubMed
  28. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  29. Castellarin M, et al. 2020. JCI Insight. 5:00. PubMed
  30. Kaiser FMP, et al. 2021. J Allergy Clin Immunol. 147:391. PubMed
  31. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  32. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  33. Diamantopoulos PT, et al. 2022. Cancers (Basel). 14:. PubMed
  34. Steindor M, et al. 2015. PLoS One. 10:119737. PubMed
  35. Todnem Sakkestad S, et al. 2019. Pathogens. 8. PubMed
  36. Kenswil KJG, et al. 2021. Exp Hematol. S0301-472X:00426. PubMed
  37. van Dongen JJM, et al. 2019. Front Immunol. 10:1271. PubMed
  38. Sananez I, et al. 2021. EBioMedicine. 72:103615. PubMed
RRID
AB_2561377 (BioLegend Cat. No. 317443) AB_2561866 (BioLegend Cat. No. 317444)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 55 kD
Distribution

T cell subset, majority of thymocytes, monocytes/macrophages

Function
MHC class II co-receptor, lymphocyte adhesion, thymic differentiation, HIV receptor
Ligand/Receptor
MHC class II molecules, HIV gp120, IL-16
Cell Type
Macrophages, Monocytes, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Center D, et al. 1996. Immunol. Today 17:476.
2. Gaubin M, et al. 1996. Eur. J. Clin. Chem. Clin. Biochem. 34:723.

Gene ID
920 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org
我要詢價(jià)
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會(huì)被公開)
*內(nèi)容:


微信客服
掃一掃立即咨詢


微信客服
掃一掃立即咨詢

銷售電話:

021-34661275

021-34661276

15301693058